Bain Capital Life Sciences Opportunities III LP 13D and 13G filings for Century Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-25 4:48 pm Purchase | 2024-04-15 | 13G | Century Therapeutics, Inc. IPSC | Bain Capital Life Sciences Opportunities III LP | 5,320,331 6.600% | 5,320,331 (New Position) | Filing |